Informações:
Falhas:
ID
29031
Descrição
A Study for Patients With Diabetes Mellitus (IOPA); ODM derived from: https://clinicaltrials.gov/show/NCT00420095
Link
https://clinicaltrials.gov/show/NCT00420095
Palavras-chave
Versões (2)
- 21/02/2018 21/02/2018 -
- 21/02/2018 21/02/2018 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
21 de fevereiro de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Diabetes Mellitus, Type 1 NCT00420095
Eligibility Diabetes Mellitus, Type 1 NCT00420095
- StudyEvent: Eligibility
Similar models
Eligibility Diabetes Mellitus, Type 1 NCT00420095
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Insulin-Dependent Diabetes Mellitus Disease length | Non-Insulin-Dependent Diabetes Mellitus Disease length
Item
clinically diagnosed type 1or type 2 diabetes for at least 2 months
boolean
C0011854 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
C0011860 (UMLS CUI [2,1])
C0872146 (UMLS CUI [2,2])
C0872146 (UMLS CUI [1,2])
C0011860 (UMLS CUI [2,1])
C0872146 (UMLS CUI [2,2])
Age
Item
aged between 18 and 70 (inclusive)
boolean
C0001779 (UMLS CUI [1])
Insulin Mix | Insulin Dosage Frequency
Item
have been treated with human insulin mix 30/70 twice daily for at least 2 months prior to entering the study
boolean
C0021641 (UMLS CUI [1,1])
C1720722 (UMLS CUI [1,2])
C0021641 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0439603 (UMLS CUI [2,3])
C1720722 (UMLS CUI [1,2])
C0021641 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0439603 (UMLS CUI [2,3])
Glycosylated haemoglobin increased
Item
have glycosylated hemoglobin (hb1ac) between 1.2 and 1.7 times the upper limit of normal reference range within 2 weeks prior to or at visit 1
boolean
C0239940 (UMLS CUI [1])
Compliance behavior Diet therapy | Compliance behavior Insulin regime | Blood Glucose Self-Monitoring Regular
Item
compliance with diet and insulin therapy and performs regular blood glucose monitoring
boolean
C1321605 (UMLS CUI [1,1])
C0012159 (UMLS CUI [1,2])
C1321605 (UMLS CUI [2,1])
C0557978 (UMLS CUI [2,2])
C0005803 (UMLS CUI [3,1])
C0205272 (UMLS CUI [3,2])
C0012159 (UMLS CUI [1,2])
C1321605 (UMLS CUI [2,1])
C0557978 (UMLS CUI [2,2])
C0005803 (UMLS CUI [3,1])
C0205272 (UMLS CUI [3,2])
Antidiabetics Oral
Item
have used oral antidiabetic agents within 30 days prior to entry into the study
boolean
C0935929 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C1527415 (UMLS CUI [1,2])
Insulin U/day
Item
receive a total daily dose of insulin >2 units/kilogram
boolean
C0021641 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
C0456683 (UMLS CUI [1,2])
Hypoglycemia Severe Episode Quantity
Item
have had more than two episodes of severe hypoglycemia within 6 months prior to entry into the study
boolean
C0020615 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0332189 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,4])
C0205082 (UMLS CUI [1,2])
C0332189 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,4])
Body mass index
Item
have a body mass index >35 kilograms per square meter (kg/m2)
boolean
C1305855 (UMLS CUI [1])
Systemic Glucocorticoids chronic
Item
receive chronic systemic glucocorticoid therapy
boolean
C3540777 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
C0205191 (UMLS CUI [1,2])